Global Biopsy Devices Market is estimated to be USD 3.8 billion by 2026 from USD 2.53 billion in 2019, at a CAGR of 6% from 2020 to 2026. Significant increase in cancer occurrence, such as breast, prostate, and lung, and fast technological advancements such as 3D optical biopsies, MRI-targeted biopsies, and Ultrasound-guided biopsies fuel the acceptance of biopsy devices. Moreover, the rise in consciousness on the diagnosis of chronic diseases fosters the demand for integrated biopsy technologies such as stereotactic-guided biopsy. However, the high cost of biopsy devices and limited accessibi